{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:46:36Z","timestamp":1790433996739,"version":"4.1.0"},"reference-count":122,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH097695"],"award-info":[{"award-number":["MH097695"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH083317"],"award-info":[{"award-number":["MH083317"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS099455"],"award-info":[{"award-number":["NS099455"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013945","name":"Institut de Recherches Servier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013945","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Prime Behavior Testing Laboratories"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,18]]},"DOI":"10.1093\/ntr\/nty166","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T15:18:12Z","timestamp":1534951092000},"page":"383-394","source":"Crossref","is-referenced-by-count":44,"title":["Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery"],"prefix":"10.1093","volume":"21","author":[{"suffix":"Jr","given":"Alvin V","family":"Terry","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA"},{"name":"Small Animal Behavior Core Laboratory, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Callahan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA"},{"name":"Small Animal Behavior Core Laboratory, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"key\n\t\t\t\t2019021810144261700_CIT0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hup.470080303","article-title":"Effects of nicotine on human psychomotor performance","volume":"8","author":"Sherwood","year":"1993","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1037\/1064-1297.2.4.345","article-title":"Nicotine and smoking: a review of effects on human performance","volume":"2","author":"Heishman","year":"1994","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0003","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09652149835864","article-title":"What aspects of human performance are truly enhanced by nicotine","volume":"93","author":"Heishman","year":"1998","journal-title":"Addiction"},{"issue":"1\u20133","key":"key\n\t\t\t\t2019021810144261700_CIT0004","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejphar.2013.01.056","article-title":"Improvement of attentional function with antagonism of nicotinic receptors in female rats","volume":"702","author":"Levin","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0091-3057(94)90237-2","article-title":"Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat","volume":"49","author":"Curzon","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"issue":"3\u20134","key":"key\n\t\t\t\t2019021810144261700_CIT0006","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002130050671","article-title":"Nicotine enhances sustained attention in the rat under specific task conditions","volume":"138","author":"Mirza","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"3\u20134","key":"key\n\t\t\t\t2019021810144261700_CIT0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050667","article-title":"Nicotinic acetylcholine involvement in cognitive function in animals","volume":"138","author":"Levin","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0924-977X(99)00002-4","article-title":"Nicotine improves memory in an object recognition task in rats","volume":"9","author":"Puma","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0024-3205(88)90318-9","article-title":"Nicotine enhances delayed matching-to-sample performance by primates","volume":"43","author":"Elrod","year":"1988","journal-title":"Life Sci"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0197-4580(91)90102-P","article-title":"Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys","volume":"12","author":"Buccafusco","year":"1991","journal-title":"Neurobiol Aging"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002130050538","article-title":"Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys","volume":"136","author":"Prendergast","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s002130050360","article-title":"Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers","volume":"132","author":"Kumari","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002130050931","article-title":"Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer\u2019s disease","volume":"143","author":"White","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"2\u20133","key":"key\n\t\t\t\t2019021810144261700_CIT0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0031-6865(99)00047-3","article-title":"Nicotinic systems in central nervous systems disease: degenerative disorders and beyond","volume":"74","author":"Newhouse","year":"2000","journal-title":"Pharm Acta Helv"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002130100899","article-title":"Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers","volume":"159","author":"Min","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0016","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.154.6.797","article-title":"The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type","volume":"154","author":"Sahakian","year":"1989","journal-title":"Br J Psychiatry"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0017","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2741\/2695","article-title":"Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer\u2019s and Parkinson\u2019s disease","volume":"13","author":"Picciotto","year":"2008","journal-title":"Front Biosci"},{"issue":"12","key":"key\n\t\t\t\t2019021810144261700_CIT0018","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.21900","article-title":"Nicotine and Parkinson\u2019s disease: implications for therapy","volume":"23","author":"Quik","year":"2008","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.0b013e31823efcbb","article-title":"Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial","volume":"78","author":"Newhouse","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"key\n\t\t\t\t2019021810144261700_CIT0021","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s40263-013-0116-4","article-title":"Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems","volume":"27","author":"Shahab","year":"2013","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0022","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcp.2017.12.008","article-title":"The wonderland of neuronal nicotinic acetylcholine receptors","volume":"151","author":"Bertrand","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0023","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1476-5381.2012.01989.x","article-title":"Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of \u03b12- and \u03b14-containing nicotinic acetylcholine receptors","volume":"167","author":"Timmermann","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"6","key":"key\n\t\t\t\t2019021810144261700_CIT0024","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/mol.54.6.1124","article-title":"Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes","volume":"54","author":"Zwart","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"6","key":"key\n\t\t\t\t2019021810144261700_CIT0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn2849","article-title":"Nicotine addiction and nicotinic receptors: lessons from genetically modified mice","volume":"11","author":"Changeux","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0026","first-page":"4","article-title":"Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments","volume":"6","author":"D\u2019Souza","year":"2011","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0027","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/187152710790966597","article-title":"Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders","volume":"9","author":"Chatterjee","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","article-title":"Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature","volume":"212","author":"Philip","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"key\n\t\t\t\t2019021810144261700_CIT0029","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"key\n\t\t\t\t2019021810144261700_CIT0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ntr\/ntt208","article-title":"Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control","volume":"16","author":"Rollema","year":"2014","journal-title":"Nicotine Tob Res"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-med-092112-142937","article-title":"\u03b17-Nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia","volume":"65","author":"Freedman","year":"2014","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0032","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.irn.2015.08.003","article-title":"Neuronal \u03b17 nicotinic receptors as a target for the treatment of schizophrenia","volume":"124","author":"Wallace","year":"2015","journal-title":"Int Rev Neurobiol"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0033","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bcp.2007.07.002","article-title":"Neuronal nicotinic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: focus on cognition","volume":"74","author":"Wilens","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"key\n\t\t\t\t2019021810144261700_CIT0034","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-014-0208-9","article-title":"Targeting the nicotinic cholinergic system to treat attention-deficit\/hyperactivity disorder: rationale and progress to date","volume":"28","author":"Potter","year":"2014","journal-title":"CNS Drugs"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1570159X11311030005","article-title":"Nicotinic receptors in neurodegeneration","volume":"11","author":"Posadas","year":"2013","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"key\n\t\t\t\t2019021810144261700_CIT0036","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/mds.25594","article-title":"Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson\u2019s disease","volume":"28","author":"Quik","year":"2013","journal-title":"Mov Disord"},{"issue":"6","key":"key\n\t\t\t\t2019021810144261700_CIT0037","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00018-010-0525-1","article-title":"Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases","volume":"68","author":"Bencherif","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0038","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bcp.2013.08.001","article-title":"Neuronal nicotinic receptors as analgesic targets: it\u2019s a winding road","volume":"86","author":"Umana","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0039","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neuropharm.2012.06.040","article-title":"Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study","volume":"64","author":"Winterer","year":"2013","journal-title":"Neuropharmacology"},{"issue":"96","key":"key\n\t\t\t\t2019021810144261700_CIT0040","first-page":"e52387","article-title":"Operant procedures for assessing behavioral flexibility in rats","volume":"15","author":"Brady","year":"2015","journal-title":"J Vis Exp"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0041","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0042","doi-asserted-by":"crossref","first-page":"e4227","DOI":"10.1371\/journal.pone.0004227","article-title":"The 5-choice continuous performance test: evidence for a translational test of vigilance for mice","volume":"4","author":"Young","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0043","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.nlm.2010.08.001","article-title":"The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning","volume":"94","author":"Raybuck","year":"2010","journal-title":"Neurobiol Learn Mem"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0044","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neulet.2010.10.058","article-title":"Nicotine enhances contextual fear memory reconsolidation in rats","volume":"487","author":"Tian","year":"2011","journal-title":"Neurosci Lett"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pbb.2011.01.009","article-title":"The use of cognitive enhancers in animal models of fear extinction","volume":"99","author":"Kaplan","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0046","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bcp.2015.07.029","article-title":"Nicotine modulation of fear memories and anxiety: implications for learning and anxiety disorders","volume":"97","author":"Kutlu","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0047","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(24)37015-6","article-title":"ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys","volume":"283","author":"Decker","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0048","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1527-3458.2004.tb00011.x","article-title":"ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders","volume":"10","author":"Rueter","year":"2004","journal-title":"CNS Drug Rev"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0049","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)37014-4","article-title":"ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties","volume":"283","author":"Sullivan","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0050","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bcp.2007.07.010","article-title":"Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys","volume":"74","author":"Buccafusco","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0051","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-3565(24)37422-1","article-title":"ABT-594 [\u00ae-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization","volume":"285","author":"Donnelly-Roberts","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0052","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pbb.2009.12.019","article-title":"ABT-594 improves performance in the 5-choice serial reaction time task under conditions of increased difficulty, sub-chronic dosing, and in poorly-performing subjects","volume":"95","author":"Mohler","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0053","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects","volume":"10","author":"Gatto","year":"2004","journal-title":"CNS Drug Rev"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019021810144261700_CIT0054","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/JMN:30:1:19","article-title":"Ispronicline: a novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties","volume":"30","author":"Lippiello","year":"2006","journal-title":"J Mol Neurosci"},{"issue":"5","key":"key\n\t\t\t\t2019021810144261700_CIT0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0278-5846(02)00205-1","article-title":"Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents","volume":"26","author":"Obinu","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0056","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ALN.0b013e3181834490","article-title":"Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug","volume":"109","author":"Cucchiaro","year":"2008","journal-title":"Anesthesiology"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0057","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00213-012-2895-6","article-title":"Effects of chronic sazetidine-A, a selective \u03b14\u03b22 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats","volume":"226","author":"Rezvani","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0058","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.110.166280","article-title":"Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior","volume":"334","author":"Turner","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"key\n\t\t\t\t2019021810144261700_CIT0059","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bcp.2009.05.033","article-title":"Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition","volume":"78","author":"Rollema","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuropharm.2012.08.004","article-title":"Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history","volume":"64","author":"Gould","year":"2013","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0061","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2016.03.025","article-title":"Effects of varenicline on alpha4-containing nicotinic acetylcholine receptor expression and cognitive performance in mice","volume":"107","author":"Lange-Asschenfeldt","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0062","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1124\/jpet.106.118976","article-title":"The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents","volume":"321","author":"Boess","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0063","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.110.167213","article-title":"In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer\u2019s disease","volume":"334","author":"Bitner","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0064","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.expneurol.2014.09.015","article-title":"The \u03b17 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions","volume":"263","author":"Bordia","year":"2015","journal-title":"Exp Neurol"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.112.197970","article-title":"Effects of the novel \u03b17 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA\/2 mice: pharmacodynamic characterization","volume":"343","author":"Radek","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"key\n\t\t\t\t2019021810144261700_CIT0066","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/bph.13001","article-title":"AQW051, a novel, potent and selective \u03b17 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation","volume":"172","author":"Feuerbach","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"7","key":"key\n\t\t\t\t2019021810144261700_CIT0067","doi-asserted-by":"crossref","first-page":"e0159996","DOI":"10.1371\/journal.pone.0159996","article-title":"The novel, nicotinic alpha7 receptor partial agonist, BMS-933043, improves cognition and sensory processing in preclinical models of schizophrenia","volume":"11","author":"Bristow","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.04.024","article-title":"Effects of BMS-902483, an \u03b17 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents","volume":"807","author":"Pieschl","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0069","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective \u03b17 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of \u03b17 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2933-4","article-title":"Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel \u03b17 nicotinic acetylcholine receptor agonist\/serotonin 5-HT3 receptor antagonist","volume":"227","author":"Boess","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0071","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.108.150094","article-title":"Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders","volume":"329","author":"Roncarati","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0072","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic \u03b17 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"key\n\t\t\t\t2019021810144261700_CIT0073","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bcp.2009.05.030","article-title":"TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia","volume":"78","author":"Hauser","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0074","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuropharm.2017.02.025","article-title":"Tropisetron sensitizes \u03b17 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals","volume":"117","author":"Callahan","year":"2017","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2010.07.037","article-title":"Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the alpha(7) nicotinic acetylcholine receptor in Wistar rats","volume":"1353","author":"Kohnomi","year":"2010","journal-title":"Brain Res"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0076","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(96)00516-3","article-title":"Different effects of tropisetron and ondansetron in learning and memory paradigms","volume":"56","author":"Pitsikas","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"19","key":"key\n\t\t\t\t2019021810144261700_CIT0077","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1073\/pnas.0701321104","article-title":"Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators","volume":"104","author":"Ng","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0078","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbr.2016.07.023","article-title":"The combination of memantine and galantamine improves cognition in rats: the synergistic role of the \u03b17 nicotinic acetylcholine and NMDA receptors","volume":"313","author":"Nikiforuk","year":"2016","journal-title":"Behav Brain Res"},{"issue":"21","key":"key\n\t\t\t\t2019021810144261700_CIT0079","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1021\/jm400704g","article-title":"Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of \u03b17 nicotinic acetylcholine receptors","volume":"56","author":"Hogenkamp","year":"2013","journal-title":"J Med Chem"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bmcl.2013.11.022","article-title":"Discovery and optimization of Lu AF58801, a novel, selective and brain penetrant positive allosteric modulator of alpha-7 nicotinic acetylcholine receptors: attenuation of subchronic phencyclidine (PCP)-induced cognitive deficits in rats following oral administration","volume":"24","author":"Eskildsen","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0081","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.107.120436","article-title":"An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo","volume":"323","author":"Timmermann","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"key\n\t\t\t\t2019021810144261700_CIT0082","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.euroneuro.2016.07.004","article-title":"Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study","volume":"26","author":"Marcus","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Pt A","key":"key\n\t\t\t\t2019021810144261700_CIT0083","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuropharm.2016.10.002","article-title":"3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the \u03b17 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats","volume":"113","author":"Potasiewicz","year":"2017","journal-title":"Neuropharmacology"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0084","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.euroneuro.2015.04.018","article-title":"Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats","volume":"25","author":"Nikiforuk","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2015.02.044","article-title":"Maximizing the effect of an \u03b17 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits","volume":"1611","author":"Stevens","year":"2015","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0086","first-page":"161","article-title":"Attention","volume-title":"Cognitive Enhancement, Handbook of Experimental Pharmacology 228","author":"Callahan","year":"2015"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0087","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bcp.2015.07.027","article-title":"Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders","volume":"97","author":"Terry","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0088","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00213-016-4236-7","article-title":"Strain dependency of the effects of nicotine and mecamylamine in a rat model of attention","volume":"233","author":"Hahn","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0089","article-title":"Spatial navigation (water maze) tasks","volume-title":"Methods of Behavior Analysis in Neuroscience","author":"Terry","year":"2009","edition":"2"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2012.10.019","article-title":"Positive allosteric modulator of \u03b17 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates","volume":"67","author":"Callahan","year":"2013","journal-title":"Neuropharmacology"},{"issue":"9, Pt B","key":"key\n\t\t\t\t2019021810144261700_CIT0091","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.neubiorev.2012.03.003","article-title":"Animal models of working memory: a review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia","volume":"37","author":"Dudchenko","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"key\n\t\t\t\t2019021810144261700_CIT0092","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0031-9384(87)90286-1","article-title":"The radial arm maze as a tool in behavioral pharmacology","volume":"40","author":"Olton","year":"1987","journal-title":"Physiol Behav"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0093","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00008877-199911000-00014","article-title":"AR-R17779, an alpha7 nicotinic agonist, improves learning and memory in rats","volume":"10","author":"Levin","year":"1999","journal-title":"Behav Pharmacol"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0094","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bcp.2013.05.018","article-title":"Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies","volume":"86","author":"Pandya","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"key\n\t\t\t\t2019021810144261700_CIT0095","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00213-013-3116-7","article-title":"A randomized, double-blind, placebo-controlled crossover study of \u03b14\u03b2 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit\/hyperactivity disorder","volume":"231","author":"Jucaite","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"key\n\t\t\t\t2019021810144261700_CIT0096","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","article-title":"Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder","volume":"68","author":"Hong","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0097","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1570159X15666171103152136","article-title":"Cognitive effects of nicotine: recent progress","volume":"16","author":"Valentine","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0098","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13195-016-0210-1","article-title":"ABT-126 monotherapy in mild-to-moderate Alzheimer\u2019s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension","volume":"8","author":"Gault","year":"2016","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0099","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/03610738708259313","article-title":"A visual recognition memory test for the assessment of cognitive function in aging and dementia","volume":"13","author":"Flicker","year":"1987","journal-title":"Exp Aging Res"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0100","first-page":"213","article-title":"Changes to the object recognition system in patients with dementia of the Alzheimer\u2019s type","volume":"49","author":"Purdy","year":"2002","journal-title":"Brain Cogn"},{"issue":"8","key":"key\n\t\t\t\t2019021810144261700_CIT0101","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0028-3932(01)00206-8","article-title":"Neural correlates of memory for object identity and object location: effects of aging","volume":"40","author":"Schiavetto","year":"2002","journal-title":"Neuropsychologia"},{"issue":"2\u20133","key":"key\n\t\t\t\t2019021810144261700_CIT0102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.schres.2004.08.017","article-title":"Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis","volume":"74","author":"Pelletier","year":"2005","journal-title":"Schizophr Res"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2008.04.011","article-title":"The cognitive neuroscience of memory function and dysfunction in schizophrenia","volume":"64","author":"Ranganath","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav Brain Res"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2536-5","article-title":"Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models","volume":"220","author":"Lyon","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0106","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2014.10.025","article-title":"Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents","volume":"285","author":"Grayson","year":"2015","journal-title":"Behav Brain Res"},{"issue":"9, Pt B","key":"key\n\t\t\t\t2019021810144261700_CIT0107","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.neubiorev.2013.09.012","article-title":"Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: the CNTRICS initiative","volume":"37","author":"Millan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019021810144261700_CIT0108","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1385\/JMN:30:1:169","article-title":"Cognitive enhancement in man with ispronicline, a nicotinic partial agonist","volume":"30","author":"Dunbar","year":"2006","journal-title":"J Mol Neurosci"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-011-2283-7","article-title":"The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL\/6J mice","volume":"217","author":"Kenney","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"key\n\t\t\t\t2019021810144261700_CIT0110","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ejn.13446","article-title":"Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome","volume":"45","author":"Pardo","year":"2017","journal-title":"Eur J Neurosci"},{"issue":"5\u20136","key":"key\n\t\t\t\t2019021810144261700_CIT0111","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.neuropharm.2012.01.008","article-title":"Nicotinic receptor activation in perirhinal cortex and hippocampus enhances object memory in rats","volume":"62","author":"Melichercik","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"key\n\t\t\t\t2019021810144261700_CIT0112","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11065-007-9040-z","article-title":"The elusive nature of executive functions: a review of our current understanding","volume":"17","author":"Jurado","year":"2007","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bandc.2008.03.003","article-title":"On the evolutionary origins of executive functions","volume":"68","author":"Ardila","year":"2008","journal-title":"Brain Cogn"},{"issue":"1\u20133","key":"key\n\t\t\t\t2019021810144261700_CIT0114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2010.11.023","article-title":"Executive function in first-episode schizophrenia: a three-year longitudinal study of an ecologically valid test","volume":"126","author":"Liu","year":"2011","journal-title":"Schizophr Res"},{"issue":"11","key":"key\n\t\t\t\t2019021810144261700_CIT0115","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","article-title":"Medial frontal cortex mediates perceptual attentional set shifting in the rat","volume":"20","author":"Birrell","year":"2000","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0116","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2016.01.006","article-title":"Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task","volume":"105","author":"Wood","year":"2016","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0117"},{"issue":"2","key":"key\n\t\t\t\t2019021810144261700_CIT0118","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"key\n\t\t\t\t2019021810144261700_CIT0119","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn2635","article-title":"Phasic acetylcholine release and the volume transmission hypothesis: time to move on","volume":"10","author":"Sarter","year":"2009","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"key\n\t\t\t\t2019021810144261700_CIT0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2013.06.016","article-title":"Animal models of CNS disorders","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pnpbp.2017.01.001","article-title":"Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: a translational meta-analysis of rodent and human studies","volume":"75","author":"Lewis","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t2019021810144261700_CIT0122","year":"2016"}],"container-title":["Nicotine & Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/21\/3\/383\/27838697\/nty166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T09:39:47Z","timestamp":1751794787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/21\/3\/383\/5078360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":122,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,8,23]]},"published-print":{"date-parts":[[2019,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/nty166","relation":{},"ISSN":["1462-2203","1469-994X"],"issn-type":[{"value":"1462-2203","type":"print"},{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,8,23]]}}}